Basic Principles in Oncology for Georgian Oncology Residents

Course Scientific Leadership

M. Kukhalashvili, G
A. Eniu, RO/C - ESO College Chair

The European School of Oncology (ESO) in collaboration with VIAN JSC and supported by the Georgian Ministry of Health, is proud to present a personalized Basic Principles in Oncology course tailored specifically for Georgian oncology residents. This course is designed to provide a comprehensive orientation to the guiding principles of multidisciplinary oncological management and complement the training provided to oncology residents in Georgia.

Oncology practice encompasses unique challenges to foster multidisciplinary with other branches of medicine. The sub-specialization in oncology has limited the exposure of junior residents to essential oncological concepts and practices. New oncology trainees face specific hurdles, including navigating an extensive curriculum without a clear starting point, adapting to a rapidly evolving clinical landscape, and managing increasing clinical demands. During their training, residents must strategically plan their careers, balance academic focus, and maintain a healthy work-life balance.

Learning Outcomes

• Update on basic principles of cancer etiology and epidemiology
• Update on basic cancer genetics, staging and imaging
• Update on basic principles of surgical oncology and pathology
• Discussion of basic principles of radiotherapy and chemotherapy
• Intro to paediatric oncology
• Intro to tumour board and patient issues: communication, supportive and palliative care
• Intro to clinical trials and paper appraisal

This event is specifically for Georgian residents and registration is on invitation only. Interested residents should contact Mariam Kukhalashvili from VIAN and the Georgian Oncologist Multidisciplinary Association or Elene Mariamidze from the Georgian School of Oncology for further details on how to register.

In collaboration with	Supported by

The course is divided into 2 parts:

Part 1: participants will view pre-recorded lectures which will be made available on the e-ESO website.

Part 2: 1.5 day in-person event

             Location: Kutaisi, Georgia

             Dates: 18 – 19 July 2025

The online learning sessions must be completed by participants before the in-person event.

This event is specifically for Georgian residents and registration is on invitation only. Interested residents should contact Mariam Kukhalashvili from VIAN and the Georgian Oncologist Multidisciplinary Association or Elene Mariamidze from the Georgian School of Oncology for further details on how to register.

Language

The course will be held in English and translation will not be provided.

Insurance

The organisers bear no responsibility for untoward events in relation to the participation in the event. Participants will be advised to take out their own personal and travel insurance coverage.

Organising secretariat

Corinne Hall
European School of Oncology
ph + 39 331 6125784
Email: chall@eso.net

Matti Aapro, Clinique de Genolier, Genolier Cancer Center, Genolier, CH
Assma Ben Aissa, Geneva University Hospital, Oncology Dpt., Geneva, CH
Stefan Bielack, Klinikum Stuttgart - Olgahospital, Dept. of Pediatric Oncology, Hematology, Immunology Dpt., Stuttgart, DE
Snezana Bosnjak, Institute of Oncology and Radiology of Serbia, Supportive Oncology & Palliative Care Dpt., Belgrade, RS
Freddie Bray, International Agency for Research on Cancer, Cancer Surveillance Branch, Lyon, FR
Jasna But Hadžic, Faculty of Medicine - University of Ljubljana, Dept. of Oncology, Ljubljana, SI
Franco Cavalli, Foundation for the Institute of Oncology Research (IOR), Presidenza, Bellinzona, CH
Tanja Cufer, University of Ljubljana, Medical Faculty, Ljubljana, SI
Giuseppe Curigliano, European Institute of Oncology / University of Milan, New Drugs for Innovative Therapies Division, Milano, IT
Urania Dafni, National and Kapodistrian University of Athens, Public Health Dpt., Goudi-Athens, GR
Berardino De Bari, Neuchâtel Hospital Network, Dept. of Radiation Oncology, La Chaux-de-Fonds, CH
Filippo De Braud, National Cancer Institute - IRCCS Foundation, Medical Oncology Dept., Milano, IT
Alexandru Eniu, Genolier Cancer Center, Clinique de Genolier, Medical Oncology Dpt., Genolier, CH
Mary Gospodarowicz, Princess Margaret Cancer Centre - University of Toronto, Dept. of Radiation Oncology, Toronto, CA
Douglas Hanahan, ISREC- Swiss Institute for Experimental Cancer, Dept. of Life Sciences, Lausanne, CH
Assia Konsoulova, National Cancer Hospital, Medical Oncology Clinic, Sofia, BG
Mariam Kukhalashvili, EVEX Medical Corporation, Oncology Dept., Kutaisi, GE
Matteo Lambertini, Policlinico San Martino Hospital – University of Genoa, Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, Genoa, IT
Erika Matos, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, SI
Olivia Pagani, Morbio Inferiore, CH
Nickolas Peradze, Ente Ospedaliero Cantonale, Gynaecology Department, Bellinzona, CH
Giancarlo Pruneri, National Cancer Institute, IRCCS Foundation, Pathology Dpt., Milano, IT
Domen Ribnikar, Institute of Oncology Ljubljana, Medical Oncology Dpt., Ljubljana, SI
Uta Schmidt-Strassburger, Ulm University, Learning and Teaching, Medical Faculty, Ulm, DE
Florian Scotté, Institute Gustave Roussy, Medical Oncology and supportive care Dpt., Villejuif, FR
Bostjan Seruga, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, SI
Petra Steyerova, General University Hospital Prague, Clinic of Radiology, Breast Cancer screening and diagnostic center, Prague 2, CZ
Ian Tannock, Princess Margaret Cancer Centre and University of Toronto, Dept. of Oncology and Hematology, Toronto, CA
Luzia Travado, Champalimaud Foundation, Champalimaud Clinical and Research Center, Lisbon, PT
Sheila Unger, Genetica, Medical Genetic Lab, Lausanne, CH
Eric Van Cutsem, University Hospital Leuven, Digestive Oncology Dept., Leuven, BE